📹 Why does intestinal fibrosis remain such a major unmet need in IBD? On 3 June, FIBROTARGET’s Bram Verstockt joins the Nordic Bioscience webinar on collagen remodelling and fibrosis looking at current challenges and new clinical insights. Register here➡️ https://loom.ly/na2rE6A

📣 This #WorldIBDDay2026, FIBROTARGET supported the global campaign on access to IBD care, highlighting ongoing gaps in diagnosis, treatment and support. ➡️ Explore FIBROTARGET's contribution here: https://loom.ly/Y5rDUNA#WorldIBDDay2026 #WorldIBDDay2026 #IBDHasNoBorders #HorizonEU

🟣🗺️ Today is #WorldIBDDay IBD Has No Borders. Access to care should not depend on geography. We support IFCCA’s call for equitable, timely IBD care worldwide and highlight the need to prevent complications like fibrosis. Learn more➡️: https://loom.ly/cVlk6EQ#WorldIBDDay #IBDHasNoBorders

#WorldIBDDay highlights the need for timely, equitable care. Early diagnosis in #IBD remains a challenge, affecting progression and outcomes. FIBROTARGET coordinator Gianluca Matteoli explains how research supports earlier detection, better tools and patient involvement. 📹 Watch the interview ⤵️

🔍Looking inside the gut: imaging tools to understand IBD fibrosis 🔬New non‑invasive imaging approaches aim to strengthen how fibrosis is detected, helping clinicians make clearer, more consistent decisions. ➡️Learn more and read the full article here: https://loom.ly/Qxk3wL4 #IBDHasNoBorders

📌 ICYMI: FIBROTARGET has released Training Academy – Module 2, focusing on in vivo fibrosis models for IBD research. Practical insights for early‑career researchers working on intestinal fibrosis 🔬 Explore the Training Academy here ➡️ https://loom.ly/wj313Io

📢Early detection should not be a privilege. ➡️In IBD, specific biomarkers have been identified that can support diagnosis and classification, help monitor disease activity, and inform the likelihood of responding to treatment. 👉Learn more: https://loom.ly/Whlbs78 #AccessToCare #IBDHasNoBorders

🎥 New reel out now! Highlights from the FIBROTARGET GAM 2026 in Barcelona: two days of scientific exchange, multistakeholder perspectives and collaboration. Hear from coordinator Gianluca Matteoli and clinical lead Bram Verstockt for more on progress. Key takeaways➡️ https://loom.ly/VX7K4iU

🚫 Fibrosis is not the same as inflammation, and once it has progressed, it often cannot be reversed. When IBD care is delayed, the risk of fibrosis and surgery increases. ➡️Understanding fibrosis supports earlier, more equitable care. Discover more!⬇️ #WorldIBDDay2026 #IBDHasNoBorders

🗺️ #WorldIBDDay2026 (19 May) reminds us: access to IBD care should not depend on geography. In the lead‑up, #FIBROTARGET will focus on intestinal fibrosis - a complication often linked to delayed diagnosis and gaps in care. Discover more➡️https://fibrotarget.eu/#WorldIBDDay2026#FIBROTARGET#IBDHasNoBorders #AccessToIBDCare

🔬🤝From Clinical Trials to Real Impact: Turning Fibrosis Research into Better Care FIBROTARGET and IFCCA recently hosted a webinar bringing together researchers, clinicians, industry and patient voices to discuss the future of fibrosis care in IBD! 📺Watch the recording: https://loom.ly/z0gezTw

🎓New training resource released: FIBROTARGET Training Academy – Module 2 This new module focuses on in vivo fibrosis models, supporting early‑career researchers working in IBD with practical training on fibrosis induction and monitoring in mice🔬. Discover the Academy!➡️ https://loom.ly/wj313Io

📣 Webinar today - don’t miss it! Join the FIBROTARGET–IFCCA webinar to explore how fibrosis research and patient voices can lead to real improvements in IBD care. 🗓️ Today | 2 April 2026 🕕 18:00–19:00 CEST | 🌐 Online Register now: https://loom.ly/RuUAO_M #IBD #Fibrosis #PatientVoice

📣 This week: FIBROTARGET–IFCCA webinar Living with IBD fibrosis? Join this free online webinar to explore how research and patient voices can lead to real improvements in care and quality of life. 📆 2 Apr • 🌐 Online Register➡️: https://loom.ly/RuUAO_M #IBD #Fibrosis #PatientVoice

🎥In this patient story, Noemi Stefanucci, a young IBD advocate from Italy and member of the IFCCA Youth Group, looks back on how the condition has shaped her life, decisions and career path. Learn more➡️https://loom.ly/yJfqEyE #IBD #DiseaseAwareness

⏳ One week to go! How can fibrosis research improve daily life for people living with IBD? Join the FIBROTARGET–IFCCA webinar to explore how patient needs and lived experience can shape better trials and future care. 📆 2 Apr • 🌐 Online • 🕕 18:00–19:00 CEST 👉 Register: https://loom.ly/Qlznsec

🌐Wrapping up the FIBROTARGET GAM 2026! Two days in Barcelona brought partners together to review progress, share insights and align on next steps. Highlights included fibrosis research, patient perspectives, imaging advances and collaboration workshops. ➡️More: https://loom.ly/VX7K4iU

🌍👥 FIBROTARGET GAM 2026 is underway in Barcelona! FIBROTARGET partners have gathered in Barcelona for our 4th GAM to present latest updates, discuss current challenges and outline future directions for the project. Stay tuned for more updates soon! 🔗 https://loom.ly/IGYRLgM

⏰Introducing the agenda for the upcoming FIBROTARGET-IFCCA webinar! 🔬From Clinical Trials to Real Impact: The Future of Fibrosis Care 📆 2 Apr 2026 • 🕕 18:00–19:00 CEST • 🌐 Online ➡️ Discover the full agenda below and register here: https://loom.ly/RuUAO_M

🎓Have you explored the FIBROTARGET Training Academy? 🎬 Module 1 explores in vitro fibrosis models using primary fibroblasts and iPSC‑derived systems - supporting early‑career scientists advancing intestinal fibrosis research. 👉 Explore: https://loom.ly/7tKSj4M

🔬WEBINAR: From Clinical Trials to Real Impact: The Future of Fibrosis Care 🌐 Online 📆2 April 2026 🕕18:00-19:00 CEST Join experts + patient voices to explore advances in fibrosis care, imaging & patient‑centred trials. ➡️ Register: https://loom.ly/RuUAO_M 💻 Learn more: https://loom.ly/Qlznsec

🎓Boost Your Hands‑On Lab Skills: Practical training for IBD Researchers! The FIBROTARGET Training Academy supports early‑career IBD researchers with hands‑on modules across key immunological techniques. 🎬 Module 1: In vitro fibrosis models ➡️ https://loom.ly/7tKSj4M #IBDResearch #Fibrosis

🥼 Curious about the future of fibrosis research in IBD? Meet us at #ECCO2026 to learn how FIBROTARGET is advancing prevention, diagnosis & treatment of intestinal fibrosis. 📍 With IFCCA at Stockholmsmässan, Booth 33, Hall A (until 21 Feb) More ➡️ https://loom.ly/IGYRLgM

🔬🔍 Did you know FIBROTARGET is advancing research to better understand and tackle intestinal fibrosis? The project has 5️⃣ publications on biomarkers, innovative lab techniques, and therapies to better understand and target fibrosis. 📖 Read more: https://loom.ly/oUyA3DU

💭 What’s it like living with fibrosis? Last year, we spoke to Anastasia Ntanou, an IBD advocate from Greece, about her 15+ years living with fibrotic Crohn’s disease. Hear her story and the misconceptions she’s faced 🎬 ➡️ Read more: https://loom.ly/QbZj4WU

Strictures. Pain. Surgery. What is intestinal fibrosis, and what is FIBROTARGET doing to combat it? Fibrosis in IBD causes scarring, pain & obstruction. No approved treatments exist. FIBROTARGET works on early detection, advanced diagnostics & clinical trials. 🌐Learn more: https://loom.ly/IGYRLgM

🎄 Happy Holidays from the FIBROTARGET project! Thank you for your continued support in advancing research on intestinal fibrosis and fibrostenosis. We wish everyone a restful festive break and look forward to sharing more of our project achievements in 2026🎉. https://fibrotarget.eu/

🌟FIBROTARGET Young Talent Spotlight! Meet Lukas Schuster, a PhD student at UK Erlangen studying pathways linked to intestinal fibrosis. He shares his insights and the role of collaboration in driving progress. Learn more here➡️https://loom.ly/ZDwhLh8

📥Stay informed on the latest in IBD fibrosis research Sign up for the FIBROTARGET newsletter for project updates, research highlights and upcoming events. Clear, accessible insights for researchers, clinicians, patients and the wider community. Join our growing network!➡️ https://loom.ly/atbot4M

🔍New FIBROTARGET Info Pill! This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity. By studying these indicators, FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care. Learn More➡️https://loom.ly/Whlbs78

🚨 Last chance! Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations Learn about the latest in intestinal fibrosis with expert & patient insights. ⏰ Register by 3 Nov: https://lnkd.in/ebXVwYpR

🎤 FIBROTARGET at the 3rd International Workshop on Liver & Gut Fibrosis in Valencia! Earlier this month, Gianluca Matteoli (KU Leuven) & Elena Ricart (Hospital Clínic de Barcelona) presented, joining experts driving forward fibrosis research. Learn more about the event ➡️ https://loom.ly/Fci-jmY

💡FIBROTARGET at #UEGWeek2025! In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials. ➡️Learn more about FIBROTARGET: https://loom.ly/IGYRLgM

🌟 Join us at #UEGWeek 2025 in Berlin! FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis! #FIBROTARGET #IBD #FibrosisResearch

📣We’re pleased to share that FIBROTARGET will be present at UEG Week 2025 in Berlin! We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us! #UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis

🔍 Interested in the latest advances in intestinal fibrosis research? Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter. Designed for researchers, clinicians & the wider community. Join here ➡️ https://loom.ly/atbot4M

Looking for reliable information on fibrosis? The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian! Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA! Download your copy 👉 https://loom.ly/yW8mEBc

Have you heard the news?🎉 FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in its 600-year history! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe. More➡️ https://loom.ly/lFmqrcI

📚 Looking for scientific publications on intestinal fibrosis and fibrostenosis? We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place. 🔗 Explore the page➡️: https://loom.ly/oUyA3DU #IBDresearch #Fibrosis

🎥 “You are everything else, and you are chronically ill.” Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are. 💬 Read their full story via FIBROTARGET: loom.ly/QbZj4WU #PatientVoices #FibrosisAwarenes

📣 New from FIBROTARGET! Can JAK-STAT signalling help treat IBD fibrosis? A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts. 🔗 Read more: loom.ly/AdfSDxo #IBD #Fibrosis

🌍 FIBROTARGET Patient Stories Meet Anastasia, a patient advocate from Greece living with fibrotic #CrohnsDisease for 15+ years. She shares her story, tackles misconceptions & offers advice for others with the condition. 📖 Read more: loom.ly/QbZj4WU

Today is #WorldIBDDay2025. We’re proud to stand with EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It. From silent symptoms to fibrotic complications, it’s time to speak up and be heard. 🔗 Discover the campaign: efcca.org/worldibdday2025

Fibrosis in IBD is real — but rarely talked about. This #WorldIBDDay2025 FIBROTARGET is working to raise awareness and improve prevention, diagnosis and treatment for intestinal fibrosis and fibrostenosis. 🟣 Let’s talk about it. #IBDHasNoBorders 🔗 fibrotarget.eu/info-pills-i...

💬It’s time to talk. #IBDHasNoBorders, and neither should our conversations. FIBROTARGET supports EFCCA's call to break taboos & speak openly about IBD, including hidden complications like fibrosis, on #WorldIBDDay2025! Let’s start now! 🔗 efcca.org/worldibdday2025

📣 New FIBROTARGET Publication! Single-cell technologies could uncover new cell types, biomarkers & pathways associated with fibrosis! These insights could lead to better diagnostics & targeted therapies 💊. 📖 Summary: fibrotarget.eu/ibd-single-c... 🗞️ Full article: gut.bmj.com/content/earl...

FIBROTARGET GAM#3 wrap-up! Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article! 📰Read our full wrap-up➡️ loom.ly/VDN6Fx4 📹Watch our highlights video below⬇️

💫 After two days of insightful discussions, strategic planning, and key project updates, the 3rd FIBROTARGET General Assembly Meeting in Milan is a wrap! 🇮🇹 A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀 #FIBROTARGET #Collaborativeresearch #HorizonEurope

FIBROTARGET GAM: Day 1 at Humanitas University in Milan Day 1 highlights: ✅ Patient insights from EFCCA ✅ New fibrosis biomarker research 🔬 ✅ Cutting-edge imaging 🏥 ✅ Laying the groundwork for a clinical trial 🏆 More soon—stay tuned! 🔍

📣New FIBROTARGET Publication! Erlangen University Hospital researchers developed an flourescent imaging method to detect fibrosis in #CrohnsDisease!🔬 ✅ Identifies #fibrosis & inflammation separately ✅ Could improve #IBD diagnosis & treatment More➡️ loom.ly/FHiDkTc